Dietary DHA supplementation in an APP/PS1 transgenic rat model of AD reduces behavioral and Aβ pathology and modulates Aβ oligomerization

Increased dietary consumption of docosahexaenoic acid (DHA) is associated with decreased risk for Alzheimer’s disease (AD). These effects have been postulated to arise from DHA’s pleiotropic effects on AD pathophysiology, including its effects on β-amyloid (Aβ) production, aggregation, and toxicity....

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neurobiol Dis
Hlavní autoři: Teng, Edmond, Taylor, Karen, Bilousova, Tina, Weiland, David, Pham, Thaidan, Zuo, Xiaohong, Yang, Fusheng, Chen, Ping-Ping, Glabe, Charles G., Takacs, Alison, Hoffman, Dennis R., Frautschy, Sally A., Cole, Gregory M.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2015
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4641021/
https://ncbi.nlm.nih.gov/pubmed/26369878
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nbd.2015.09.002
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky